What is the average H1B salary for a Sr. Specialist, Quality Assurance?

The median filed base salary for Sr. Specialist, Quality Assurance H-1B LCA records is $128,446 per year.

How many Sr. Specialist, Quality Assurance H-1B LCA filings are in this dataset?

There are 6 Labor Condition Applications filed for the Sr. Specialist, Quality Assurance role in the available dataset.

Which employers file H-1B LCAs for Sr. Specialist, Quality Assurance?

Top employers filing LCAs for Sr. Specialist, Quality Assurance include ModernaTX, Inc., Revance Therapeutics, Inc., PepGen Inc..

Sr. Specialist, Quality Assurance

SOC Code: 19-4021.00

SOC Category: Biological Technicians

LCA FY2024-FY2026 · PERM FY2024-FY2025 · USCIS Employer Data Hub 2023 · BLS OEWS May 2023

Median Salary

$128,446

H-1B LCA Filings

6LCA records

Top 10% Salary

$145,000

Data caveat

Public filing data is normalized for browsing. LCA filings are not visa approvals or job openings, PERM filings are not individual green-card success rates, and salary figures generally exclude equity, bonus, and benefits.

Salary Distribution (Base)

$128,446

P25: $110,000

P75: $141,369

Min: $87,500Max: $145,000

Top Sponsoring Employers

ModernaTX, Inc.2 filings
$101,512
Revance Therapeutics, Inc.2 filings
N/A
PepGen Inc.1 filings
$110,000
The Nasdaq Stock Market LLC1 filings
$141,369

Highest Paying Cities

Philadelphia, PA1 filings
$141,369
Boston, MA1 filings
$110,000
Norwood, MA2 filings
$101,512
Newark, CA2 filings
N/A

Frequently Asked Questions

What is the average H1B salary for a Sr. Specialist, Quality Assurance?: The median filed base salary for Sr. Specialist, Quality Assurance H-1B LCA records is $128,446 per year.
How many Sr. Specialist, Quality Assurance H-1B LCA filings are in this dataset?: There are 6 Labor Condition Applications filed for the Sr. Specialist, Quality Assurance role in the available dataset.
Which employers file H-1B LCAs for Sr. Specialist, Quality Assurance?: Top employers filing LCAs for Sr. Specialist, Quality Assurance include: ModernaTX, Inc., Revance Therapeutics, Inc., PepGen Inc..